Name Development Level Target Family
Name Description
aflibercept has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders
TCRDv5.2.0
DrugCentral Indication
aflibercept